A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants

The severity of symptoms as well as efficacy of antidepressants in major depressive disorder (MDD) is modified by single nucleotide polymorphisms (SNPs) in different genes, which may contribute in an additive or synergistic fashion. We aimed to investigate depression severity in participants with MD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Dev Res
Main Authors: Kanders, Sofia H., Pisanu, Claudia, Bandstein, Marcus, Jonsson, Jörgen, Castelao, Enrique, Pistis, Giorgio, Gholam‐Rezaee, Mehdi, Eap, Chin B., Preisig, Martin, Schiöth, Helgi B., Mwinyi, Jessica
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028038/
https://ncbi.nlm.nih.gov/pubmed/31617956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21609
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados